Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients.

Abstract:

OBJECTIVES:It was the aim of this study to investigate the clinical differences between the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib as second-line treatment for cytokine-refractory kidney cancer patients. METHODS:Twenty consecutive patients received continuous treatment of oral sorafenib at a dose of 400 mg twice daily in 6-week cycles. Sunitinib was administered to the remaining 20 patients at 50 mg once daily in repeated 6-week cycles consisting of daily therapy for 4 weeks, followed by a 2-week off-treatment period. We correlated best treatment responses and progression-free survival (PFS) with either TKI treatment. Adverse events were evaluated and differences were compared between both treatment groups. RESULTS:In the sorafenib group, 2 (10%) patients showed a partial response (PR) and 4 (20%) patients had progressive disease (PD) versus 6 (30%) PRs and 3 (15%) PDs in the sunitinib group, respectively (p = 0.195). The median PFS was 6.4 months for sorafenib and 7.4 months for sunitinib (p = 0.969). In contrast to gender, age and the number of prior cytokine therapy cycles, the Eastern Cooperative Oncology Group performance status (p = 0.024) and the Memorial Sloan-Kettering Cancer Center risk groups for second-line treatments (p = 0.015) were independent predictive parameters of PFS. Gastrointestinal symptoms were found to occur with greater frequency in the sunitinib group (p = 0.03). CONCLUSIONS:Both TKIs showed comparable clinical benefits. The Eastern Cooperative Oncology Group performance status and the Memorial Sloan-Kettering Cancer Center risk groups can help determine which patients might benefit from alternative drug treatments.

journal_name

Oncology

journal_title

Oncology

authors

Herrmann E,Bierer S,Gerss J,Köpke T,Hertle L,Wülfing C

doi

10.1159/000151369

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

216-22

issue

3-4

eissn

0030-2414

issn

1423-0232

pii

000151369

journal_volume

74

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Value of serum neuron-specific enolase in nonsmall cell lung cancer.

    abstract::To assess the prognostic value of pretreatment serum neuron-specific enolase (NSE) in nonsmall cell lung cancer (NSCLC), levels were measured in 84 NSCLC patients, 40 healthy controls, and 20 patients with benign pulmonary diseases. NSE concentration was higher in NSCLC (11.7 +/- 10.8 ng/ml) (mean +/- SD; median = 9.7...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227163

    authors: Diez M,Torres A,Ortega L,Maestro M,Hernando F,Gomez A,Picardo A,Granell J,Balibrea JL

    更新日期:1993-03-01 00:00:00

  • Pharmacokinetics of a new fentanyl tape with a novel delivery system of transdermal matrix patches in patients with cancer pain.

    abstract:OBJECTIVES:A novel delivery system for transdermal matrix patches of fentanyl has been developed. The new fentanyl tape consists of a backing layer, a drug-containing layer and a release liner that is originally made of rubber adhesive. This open-label prospective study investigated the pharmacokinetics and safety of t...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000356625

    authors: Saito T,Fujii M,Saito S,Shimada K,Fujiwara K,Kobayashi K

    更新日期:2014-01-01 00:00:00

  • Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.

    abstract::Nicotinamide, the amide derivative of vitamin B(3), cooperates with retinoic acid (RA), a form of vitamin A, and 1,25-dihydroxyvitamin D(3) (D3), to regulate cell differentiation and proliferation of human myeloblastic leukemia cells. In human myeloblastic leukemia cells, RA or D3 are known to cause MAPK signaling lea...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000188664

    authors: Shen M,Yen A

    更新日期:2009-01-01 00:00:00

  • Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.

    abstract::Two randomized controlled trials identified that transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) shows a significant survival benefit compared with controls, after a long-term controversy. Thus, TACE is the current standard of care for patients presenting with multinodular HCC. Monit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000345891

    authors: Minami Y,Kudo M

    更新日期:2013-01-01 00:00:00

  • Side effects of ifosfamide.

    abstract::Ifosfamide is relatively well tolerated but it can be associated occasionally with life-threatening complications such as arrhythmias and heart failure, severe encephalopathy and hemorrhagic cystitis. Mesna administration can control the urothelial toxicity of ifosfamide, but it is without effect on the other complica...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000073351

    authors: Klastersky J

    更新日期:2003-01-01 00:00:00

  • Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis.

    abstract:OBJECTIVE:Serrated adenoma (SA) consists of glands both with intraluminal projection of tall columnar cells, which resemble the terminally differentiated cells in the surface epithelium, and with concave short cells, which resemble progenitor crypt cells of the colon. The aim of this study was to clarify the relationsh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151359

    authors: Jiao YF,Nakamura S,Sugai T,Yamada N,Habano W

    更新日期:2008-01-01 00:00:00

  • Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

    abstract::Sodium cyanate, a drug that selectively suppresses amino acid incorporation for protein synthesis in tumor tissue, was given to patients with advanced colorectal carcinoma who had failed to conventional therapy, with the purpose of assessing a maximum tolerable oral dose. At 35 mg/kg p.o. daily, the drug had to be sto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226038

    authors: Herrera-Ornelas L,Petrelli NJ,Madajewicz S,Mittelman A,Allfrey VG

    更新日期:1985-01-01 00:00:00

  • Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

    abstract:OBJECTIVES:To assess the feasibility and efficacy of intensity-modulated radiation implemented with helical tomotherapy image-guided with daily megavoltage computed tomography for head and neck cancer. METHODS:Between May 2010 and May 2013, 72 patients were treated with curative intent. The median age was 64 years, wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000489217

    authors: Santa Cruz O,Tsoutsou P,Castella C,Khanfir K,Anchisi S,Bouayed S,Matzinger O,Ozsahin M

    更新日期:2018-01-01 00:00:00

  • Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.

    abstract::Of 352 patients with colorectal carcinoma followed for a minimum of 5 years after surgery, 39 cases (11.1%; median age 60 years) had mucinous adenocarcinoma, and 4 (1.1%; median age 62 years) had signet-ring cell carcinoma. Mucinous carcinomas were most frequently located in the rectum (61.5%) and in the sigmoid colon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227306

    authors: Secco GB,Fardelli R,Campora E,Lapertosa G,Gentile R,Zoli S,Prior C

    更新日期:1994-01-01 00:00:00

  • Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.

    abstract::203 tumor specimens from 175 patients were studied. Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer. We failed to find more than one copy of ERBB-2...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227032

    authors: Knyazev PG,Imyanitov EN,Chernitca OI,Nikiforova IF,Hanson KP

    更新日期:1992-01-01 00:00:00

  • Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

    abstract:BACKGROUND:Whether recurrence after surgery and primary metastatic pancreatic cancer should be included in the same category when conducting gemcitabine-based clinical trials remains controversial. OBJECTIVE:To clarify the outcomes of recurrent and metastatic pancreatic cancers. METHODS:326 patients who received gemc...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000236022

    authors: Hashimoto K,Ueno H,Ikeda M,Kojima Y,Hagihara A,Kondo S,Morizane C,Okusaka T

    更新日期:2009-01-01 00:00:00

  • Aspirin shares a short-term effect, inhibition of pyruvate kinase activity with tumor-promoting agents, but fails to promote rat liver carcinogenesis.

    abstract::Since aspirin was found to cause a persistent decrease in pyruvate kinase activity, which is a prominent characteristic of the hepatic promoters, the effect of aspirin on hepatic tumorigenesis in the rat has been studied. Male Wistar rats were initiated with a diet containing 0.06% 3'-methyl-4-dimethylamino-azobenzene...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227195

    authors: Yanagi S,Yamashita M,Hiasa Y

    更新日期:1993-07-01 00:00:00

  • Immunohistological approach to tumor diagnosis.

    abstract::Immunoperoxidase methods permit the demonstration of a variety of antigens in routinely processed tissues. The morphological detail obtained by this procedure is comparable to orthodox haematoxylin and eosin stained sections, and so offers the diagnostic pathologist the opportunity of simultaneously identifying normal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:

    authors: Taylor CR

    更新日期:1978-01-01 00:00:00

  • High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.

    abstract::Oral cancer is the eleventh most common cancer globally, with well-established major risk factors of tobacco, areca nut, alcohol, and high-risk human papillomavirus (HR-HPV) types 16 and 18. HR-HPV16/18 are the etiologic agents of cervical cancers and a proportion of oropharyngeal cancers. HPV-associated oropharyngeal...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000485322

    authors: Yete S,D'Souza W,Saranath D

    更新日期:2018-01-01 00:00:00

  • Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma.

    abstract:OBJECTIVE:To assess the efficacy of percutaneous cementoplasty for painful bone metastasis from hepatocellular carcinoma (HCC). METHODS:Cementoplasty was performed for 22 metastatic bone tumors in 13 patients. All patients had intractable pain and were diagnosed as metastatic bone tumor from HCC. The ostyneedle was in...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000113040

    authors: Kodama H,Aikata H,Uka K,Takaki S,Mori N,Waki K,Jeong SC,Kawakami Y,Shirakawa H,Takahashi S,Toyota N,Ito K,Chayama K

    更新日期:2007-01-01 00:00:00

  • Pre- and postsurgery activation of blood coagulation in gastric and large bowel cancers: diagnostic, therapeutic and prognostic hints.

    abstract::In 12 patients with gastric cancer and in 14 with large bowel neoplasia, classified according to the TNM system, some major blood indices of hemostasis, platelet activation and fibrinolysis were assessed before and for 1 month after surgery, to show whether possible variations of such indices may provide useful clues ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226828

    authors: Abbasciano V,Guerra S,Reali MG,Guglielmini C

    更新日期:1990-01-01 00:00:00

  • Phase II study of AMSA and doxorubicin to treat metastatic breast cancer.

    abstract::Twenty-two evaluable patients with metastatic breast cancer were treated with a combination of 4-(acridinylamino)methanesulfon-m-anisidide (AMSA) and doxorubicin. All patients but one had received prior therapy with fluorouracil, cyclophosphamide, and methotrexate. Eight patients had partial responses (36%) with a med...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226365

    authors: Casimir MT,Buzdar AU,Blumenschein GR,Hortobagyi GN,Bodey GP

    更新日期:1986-01-01 00:00:00

  • Impact of Socioeconomic Status and Ethnicity on Melanoma Presentation and Recurrence in Caucasian Patients.

    abstract:OBJECTIVES:The impact of ethnicity and the socioeconomic status (SES) among Caucasians is not well studied. Here, we examine the impact of income on melanoma presentation and prognosis within a Caucasian cohort, accounting for ethnicity, as some reports suggest increased melanoma incidence in Ashkenazi Jewish (AJ) BRCA...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000441524

    authors: Salvaggio C,Han SW,Martires K,Robinson E,Madankumar R,Gumaste P,Polsky D,Stein J,Berman R,Shapiro R,Zhong J,Osman I

    更新日期:2016-01-01 00:00:00

  • A New Transcutaneous Method for Breast Cancer Detection with Dogs.

    abstract::We developed a new transcutaneous method for breast cancer detection with dogs: 2 dogs were trained to sniff skin secretion samples on compresses that had been worn overnight by women on their breast, and to recognize a breast cancer sample among 4 samples. During the test, the dogs recognized 90.3% of skin secretion ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492895

    authors: Thuleau A,Gilbert C,Bauër P,Alran S,Fourchotte V,Guillot E,Vincent-Salomon A,Kerihuel JC,Dugay J,Semetey V,Kriegel I,Fromantin I

    更新日期:2019-01-01 00:00:00

  • Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.

    abstract:OBJECTIVE:The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity. METHODS:Patients who received oxaliplatin-containing regimens after curative resection for colorectal carcinoma from 10 different o...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1159/000336902

    authors: Uncu D,Aksoy S,Çetin B,Yetişyiğit T,Özdemir N,Berk V,Dane F,Inal A,Harputluoğlu H,Budakoğlu B,Koca D,Sevinç A,Cihan S,Durnalı AG,Özkan M,Öztürk MA,Işıkdoğan A,Büyükberber S,Benekli M,Köş T,Alkış N,Karaca H,Tur

    更新日期:2013-01-01 00:00:00

  • 17-beta-hydroxysteroid dehydrogenase in human breast and endometrial carcinoma. A new development in intracrinology.

    abstract::Intratumoral metabolism and synthesis of estrogens are considered to play very important roles in the pathogenesis and development of various sex steroid-dependent neoplasms including breast and endometrial carcinoma. 17 beta-Hydroxysteroid dehydrogenase (17 beta-HSD) isozymes catalyze the interconversion of estradiol...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055281

    authors: Sasano H,Suzuki T,Takeyama J,Utsunomiya H,Ito K,Ariga N,Moriya T

    更新日期:2000-01-01 00:00:00

  • A case-control study of breast cancer and psychotropic drug use.

    abstract::The relative risk of breast cancer incidence and tumor promotion associated with psychotropic drug consumption was evaluated in 151 patients with newly diagnosed neoplasms and 151 hospital controls. No significantly altered risk of breast cancer was found in association with the use of diazepam, chlordiazepoxide, anti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225651

    authors: Wallace RB,Sherman BM,Bean JA

    更新日期:1982-01-01 00:00:00

  • Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.

    abstract::The role of estrogen and estrogen-related growth factors in the mechanism of hormone dependency of endometrial adenocarcinoma cells was investigated. The proliferation of hormone-responsive human endometrial adenocarcinoma cells (Ishikawa cells), which possess both estrogen and progesterone receptors, was optimally st...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055257

    authors: Hata H,Hamano M,Watanabe J,Kuramoto H

    更新日期:1998-12-01 00:00:00

  • Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.

    abstract::We investigated the effects of piroxicam, a cyclooxygenase inhibitor, and esculetin, a lipoxygenase inhibitor, on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female rats. Seven days after receiving a 5-mg dose of DMBA, rats were fed either a high-fat (20% soybean oil) or low-fat (0.5% soybe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227374

    authors: Kitagawa H,Noguchi M

    更新日期:1994-09-01 00:00:00

  • Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.

    abstract::Coagulation disorders are frequently detected in patients affected by different tumours even though clinical symptoms occur in a very small percentage of such subjects. Coagulation processes are probably involved in the mechanism of metastatic spread. We assayed the plasma levels of thrombin-antithrombin III (TAT) com...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227086

    authors: Bartoloni C,Guidi L,Tricerri A,Patriarca F,Pili R,Cursi F,Canetta M,Cappelli A,Vangeli M,Salvati F

    更新日期:1992-01-01 00:00:00

  • Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma.

    abstract:OBJECTIVE:Transarterial chemoembolization (TACE) is recommended as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for curative therapy and without portal invasion. The Assessment for Retreatment with TACE (ART) scoring system was recently proposed for identifying patients who would not show...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000440625

    authors: Arizumi T,Ueshima K,Iwanishi M,Minami T,Chishina H,Kono M,Takita M,Kitai S,Inoue T,Yada N,Hagiwara S,Ida H,Minami Y,Sakurai T,Nishida N,Kitano M,Kudo M

    更新日期:2015-01-01 00:00:00

  • Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.

    abstract::Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurable disease on entry into the study. No responses were observed while 3 patients,...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226836

    authors: Benedetti Panici P,Scambia G,Greggi S,Salerno G,Cento R,Mancuso S

    更新日期:1990-01-01 00:00:00

  • Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas.

    abstract::A pilot study was performed administering PCNU with radiation therapy to treat patients with high-grade astrocytomas and to explore the toxic effects of this drug regimen. PCNU at an initial dose of 110 mg/m2 i.v. was administered to 14 patients within 4 weeks after completion of cranial irradiation. Courses were repe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226854

    authors: Feun LG,Maor M,Stewart DJ,Leavens ME,Savaraj N,Bodey GP

    更新日期:1990-01-01 00:00:00

  • HER2 as a prognostic factor in breast cancer.

    abstract::HER2 amplification/overexpression is a marker of poor prognosis in breast cancer. The prognostic impact of HER2 positivity is lower in node-negative compared with node-positive women. The only significant, independent prognostic factors in breast cancer are node status, HER2 status and menopausal status. HER2-positive...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055404

    authors: Ménard S,Fortis S,Castiglioni F,Agresti R,Balsari A

    更新日期:2001-01-01 00:00:00

  • The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer.

    abstract:AIMS:We investigated the relationship between serum leptin concentrations and polymorphism of the leptin receptor gene and breast cancer. METHODS:Serum leptin concentrations were measured by enzyme-linked immunosorbent assay in 47 women with invasive breast cancer compared with 41 age-matched controls without cancer. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000111097

    authors: Liu CL,Chang YC,Cheng SP,Chern SR,Yang TL,Lee JJ,Guo IC,Chen CP

    更新日期:2007-01-01 00:00:00